Safety and Efficiency of γδ T Cell Against Breast Cancer

NCT03183206 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fuda Cancer Hospital, Guangzhou

Collaborators